The present invention discloses novel compounds of Formula (I) or
pharmaceutically acceptable salts thereof, which have histamine-H3
receptor antagonist or inverse agonist activity, as well as methods for
preparing such compounds. In another embodiment, the invention discloses
pharmaceutical compositions comprising compounds of Formula (I) as well
as methods of using them to treat obesity, cognitive deficiencies,
narcolepsy, and other histamine H3 receptor-related diseases.
##STR00001##